Samir Kaul, Director at Guardant Health, Inc. (GH), sold 17,800 shares at $101.14 ($1.8M) on 2020-09-17, disclosed to the SEC on 2020-09-21.
Open-market sale of $1.8M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.23 | 1,000 | $99K | 5.5% |
| 2 | $100.35 | 3,286 | $330K | 18.4% |
| 3 | $100.35 | 3,286 | $330K | 18.4% |
| 4 | $101.14 | 4,514 | $457K | 25.4% |
| 5 | $101.14 | 4,514 | $457K | 25.4% |
| 6 | $102.26 | 1,200 |
| $123K |
| 6.8% |
| Total | $100.82 avg | 17,800 | $1.8M | 100% |
| Filing → |
| GH | SELL | 2020-10-20 | $2.0M | — | Filing → |
| GH | SELL | 2020-08-19 | $1.7M | — | Filing → |
| GH | SELL | 2020-03-06 | $2.1M | — | Filing → |